SCHEMBL7947655

SCHEMBL7947655

C1CCC(NCCCN2CCCC2)CC1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAD52 P43351 2/20 0.58
SMN1; SMN2 Q16637 3/20 0.51
LMNA P02545 1/20 0.51
HRH3 Q9Y5N1 5/20 0.50
CYP2C9 P11712 1/20 0.46
EPHX1 P07099 1/20 0.45
GAA P10253 1/20 0.45
TP53 P04637 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
TSHR P16473 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CXCR4 P61073 2/20 0.43
CXCL12 P48061 1/20 0.43
KCNH2 Q12809 1/20 0.41
SIGMAR1 Q99720 2/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20614282 1.00 RAD52 (0.58) RAD52SMN1; SMN2LMNAHRH3CYP2C9
SCHEMBL6973435 0.98 RAD52 (0.55) RAD52SMN1; SMN2LMNAHRH3CYP2C9
SCHEMBL6493217 0.94 RAD52 (0.59) RAD52SMN1; SMN2LMNAHRH3CYP2C9
SCHEMBL6503351 0.94 RAD52 (0.59) RAD52SMN1; SMN2LMNAHRH3CYP2C9
SCHEMBL3446318 0.88 RAD52 (0.72) RAD52SMN1; SMN2HRH3CYP2C9CYP1A2
SCHEMBL13045564 0.85 GAA (0.62) RAD52SMN1; SMN2LMNAEPHX1GAA
SCHEMBL7511788 0.85 RAD52 (0.51) RAD52SMN1; SMN2LMNAHRH3CYP2C9
SCHEMBL11507 0.85 HRH3 (0.48) RAD52SMN1; SMN2LMNAHRH3CYP2C9
SCHEMBL13771289 0.85 GAA (0.62) RAD52SMN1; SMN2LMNAEPHX1GAA
SCHEMBL17484488 0.85 RAD52 (0.60) RAD52SMN1; SMN2LMNAHRH3CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010035032-A1 CALCIUM ION CHANNEL MODULATORS & USES THEREOF LECTUS THERAPEUTICS LIMITED (GB) 2010-04-01 WO disclosed
WO-2009133387-A1 INDOLE- 3 -GLYOXYLAMIDE DERIVATIVES FOR USE AS CALCIUM ION CHANNEL MODULATORS LECTUS THERAPEUTICS LIMITED (GB) 2009-11-05 WO disclosed